BGI was established for the Human Genome Project.

At the beginning of 2008, BGI-Research, Sanger Institute and National Human Genome Research Institute launched the 1000 Genomes Project. The results were published in Nature as a cover story on October 28, 2010.

The international research consortium for the 1000 Genomes Project (a large-scale international scientific research cooperation project) published in Nature an integrated map of genetic variation of human genomes based on the analysis of DNA variation of 1,092 individuals. BGI, as one of the initiat...

NIFTY, BGI’s NIPT test, became the first second-generation gene sequencing and testing product in the world approved and registered by the China Food and Drug Administration.

MGI’s automatic MGISTP-7000 aliquot processing system was certified as a Class-I medical device by the National Medical Products Administration (NMPA), which was founded on the basis of the former China Food and Drug Administration.